(All fields required)
Please enter a valid email.
Please enter your name.
High doses of steroids to treat infants with biliary atresia after surgery fails to improve medical outcomes and is associated with earlier onset of serious adverse events. Read more
As he approaches his 40th year of service at Cincinnati Children’s, Heubi is enjoying a new leadership role. Read More »
A core team of specialists will provide rapid diagnosis and effective therapies—including pain management—for children with pancreatic diseases. Read more »
Severe cases of inflammatory bowel disease (IBD) have a specific microbial and genetic signature. Read more »
The Cincinnati Children’s GI faculty is growing! Meet our four newest team members. Read more »
RSVP by Nov. 1 to attend our Alumni & Friends Reception in Boston on Nov. 7 during the AASLD Liver Meeting. Read more »
The steroid fluticasone propionate proves effective for most patients, but not for a specific group. And a new genetic finding may lead to improved treatment. Read more »
A scientist here is creating a mouse model with the goal of preventing and treating environmental enteropathy. This research project is made possible by a $1 million grant from the Gates Foundation. Read more »
Register today for Pediatric Insights, our monthly e-newsletter for physicians. Receive the latest information on clinical advancements, research updates and news from Cincinnati Children's.
Subscribe Now >>
3333 Burnet Avenue, Cincinnati, Ohio 45229-3026 | 1-513-636-4200 | 1-800-344-2462 | TTY: 1-513-636-4900
New to Cincinnati Children’s or live outside of the Tristate area? 1-877-881-8479
© 1999-2015 Cincinnati Children's Hospital Medical Center